On November 20, 2025 PTC Therapeutics, Inc. (NASDAQ: PTCT) reported that it will host an R&D Day to discuss its pipeline on Dec. 2, 2025, at 9:30 a.m. EST in New York City. The event will also be webcast.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Matthew B. Klein, M.D., Chief Executive Officer, and PTC research and development team leaders will provide an update on the company’s proprietary small molecule splicing and inflammation platforms, including new targets and programs.

To register for the webcast, please visit the Events and Presentations page on the Investors section of the PTC Therapeutics website at View Source A replay will be available for approximately 30 days following the event.

(Press release, PTC Therapeutics, NOV 20, 2025, View Source [SID1234660850])